Related Experiment Videos
Renaissance of immunosuppressive therapy in the new millennium
1Department of Surgery, University of Texas Medical School at Houston 77030, USA. bkahan@orgtx71.med.uth.tmc.edu
Transplantation Proceedings
|September 2, 1998
Summary
Future immunosuppression strategies must balance patient survival with co-morbidity, cost, and convenience. Achieving optimal transplantation outcomes requires novel scientific and informational technologies tailored to individual patient needs.
Area of Science:
- Transplantation immunology
- Medical technology development
Background:
- Current immunosuppression focuses on graft survival.
- Future strategies must integrate patient co-morbidity, cost, and convenience (the "Three C's").
Purpose of the Study:
- To outline the future technological needs for optimizing immunosuppression.
- To emphasize a patient-centered approach for improved transplantation outcomes.
Main Methods:
- Conceptual framework development for future immunosuppression.
- Identification of necessary advancements in drug design, testing, and implementation.
- Highlighting the need for informational tools like databases and theoretical models.
Main Results:
- The "Three C's" (Co-morbidity, Cost, Convenience) are critical for 21st-century immunosuppression.
- New scientific and informational technologies are urgently required.
- A strategic vision for adopting and harnessing technology is essential.
Conclusions:
- Optimizing immunosuppression necessitates a holistic approach beyond graft survival.
- Patient-specific outcomes, including quality of life, are paramount.
- Technological innovation is key to achieving personalized and effective transplantation care.